Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Menopausal Gonadotropin as a Novel Addition to Luteal Phase Support in Down-regulated ICSI Cycles (RCT)

NCT03209687 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT03209687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03209687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Menopausal Gonadotropin as a Novel Addition to Luteal Phase Support in Down-regulated ICSI Cycles (RCT)
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Completed
Start date
July 6, 2017
Completion date
August 15, 2024
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility